A TNF-induced gene expression program under oscillatory NF-κB control

BackgroundThe cytokine tumor necrosis factor (TNF) initiates tissue inflammation, a process mediated by the NF-κB transcription factor. In response to TNF, latent cytoplasmic NF-κB is activated, enters the nucleus, and induces expression of inflammatory and anti-apoptotic gene expression programs. Recently it has been shown that NF-κB displays two distinct activation modes, monophasic and oscillatory, depending on stimulus duration. Characterization of temporal expression patterns for the NF-κB network and determination of those genes under monophasic- or oscillatory control has not been experimentally addressed.ResultsTo identify the kinetics of NF-κB-dependent gene expression and determine whether these two types of NF-κB translocation modes control distinct gene programs, a detailed kinetic analysis of a validated microarray data set was performed on 74 unique NF-κB-dependent genes in response to TNF. Hierarchical clustering identified distinct expression profiles termed the "Early", "Middle", "Late" response groups, peaking 1, 3, and 6 h after stimulation, respectively. These expression patterns were validated by Quantitative Real Time PCR (Q-RT-PCR) and NF-κB binding was demonstrated by chromatin immunoprecipitation (ChIP) assays. Each response group was mapped to its molecular function; this analysis indicated that the Early group encodes cytokines or negative regulators of the IKK-NF-κB pathway, and the Late group encodes cell surface receptors, adhesion molecules and signal adapters. That similar coordinated sequential cascades of gene expression were also seen in response to stimulation by the cytokine IL-1, and expression patterns observed in MRC-5 fibroblasts indicated that the epithelial NF-κB program is relatively stimulus- and cell type-independent. Bioinformatic analysis of the Early and Late gene promoters indicates that although both groups contain similar patterns of NF-κB-binding sites, only the Early gene promoters contain NF-κB-binding sites located in phylogenetically conserved domains. Stimulation protocols designed to produce either monophasic or oscillatory NF-κB activation modes showed that the oscillatory mode is required only for expression of the Late genes.ConclusionThis analysis provides important insights into the TNF-regulated genetic response program in epithelial cells, where NF-κB controls sequential expression patterns of functionally distinct genes that depend on its oscillatory activation mode.

[1]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[2]  A. Brasier,et al.  Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation. , 1999, The Journal of biological chemistry.

[3]  T. Maniatis Catalysis by a Multiprotein IκB Kinase Complex , 1997, Science.

[4]  A. Krikos,et al.  Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. , 1992, The Journal of biological chemistry.

[5]  M. Klemsz,et al.  Cloning and Characterization of Exodus, a Novel β-Chemokine , 1997 .

[6]  T. Standiford,et al.  Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. , 1990, The Journal of clinical investigation.

[7]  Jiahuai Han,et al.  Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and Threonine (*) , 1995, The Journal of Biological Chemistry.

[8]  A. Brasier,et al.  Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. , 1996, Hypertension.

[9]  H. Pahl,et al.  Activators and target genes of Rel/NF-kappaB transcription factors. , 1999, Oncogene.

[10]  S. Saccani,et al.  Two Waves of Nuclear Factor κb Recruitment to Target Promoters , 2001, The Journal of experimental medicine.

[11]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[12]  Hong-Bing Shu,et al.  TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.

[13]  A. Brasier,et al.  Mechanism for Biphasic Rel A· NF-κB1 Nuclear Translocation in Tumor Necrosis Factor α-stimulated Hepatocytes* , 1997, The Journal of Biological Chemistry.

[14]  A. Hoffmann,et al.  The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .

[15]  Terry Farrah,et al.  The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death , 1994, Cell.

[16]  Somasekar Seshagiri,et al.  De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling , 2004, Nature.

[17]  A. Ting,et al.  A20 Inhibits Tumor Necrosis Factor (TNF) Alpha-Induced Apoptosis by Disrupting Recruitment of TRADD and RIP to the TNF Receptor 1 Complex in Jurkat T Cells , 2002, Molecular and Cellular Biology.

[18]  K. Senger,et al.  Mechanism by which the IFN-beta enhanceosome activates transcription. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Brasier,et al.  NF-κB-inducible BCL-3 Expression Is an Autoregulatory Loop Controlling Nuclear p50/NF-κB1 Residence* , 2001, The Journal of Biological Chemistry.

[20]  D. Goeddel,et al.  The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  E. Ainbinder,et al.  Mechanism of Rapid Transcriptional Induction of Tumor Necrosis Factor Alpha-Responsive Genes by NF-κB , 2002, Molecular and Cellular Biology.

[22]  T. Maniatis Catalysis by a multiprotein IkappaB kinase complex. , 1997, Science.

[23]  A. Brasier,et al.  Mechanisms for inducible control of angiotensinogen gene transcription. , 1996, Hypertension.

[24]  B. Beutler TNF, immunity and inflammatory disease: lessons of the past decade. , 1995, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[25]  D B Kell,et al.  Oscillations in NF-kappaB signaling control the dynamics of gene expression. , 2004, Science.

[26]  L. Pachter,et al.  rVista for comparative sequence-based discovery of functional transcription factor binding sites. , 2002, Genome research.

[27]  M. Sinha,et al.  Identification of NF-κB-Dependent Gene Networks in Respiratory Syncytial Virus-Infected Cells , 2002, Journal of Virology.

[28]  Marek Kimmel,et al.  Stochastic effects of multiple regulators on expression profiles in eukaryotes. , 2005, Journal of theoretical biology.

[29]  Young Chul Park,et al.  All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. , 2002, Journal of cell science.

[30]  G Cantarella,et al.  Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. , 2000, Immunity.

[31]  Kevin Gardner,et al.  Kinetic profiles of p300 occupancy in vivo predict common features of promoter structure and coactivator recruitment. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Baldwin,et al.  The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. , 1993, Genes & development.

[33]  M. Beato Chromatin structure and the regulation of gene expression: remodeling at the MMTV promoter , 1996, Journal of Molecular Medicine.

[34]  Michael Karin,et al.  The Beginning of the End: IκB Kinase (IKK) and NF-κB Activation* , 1999, The Journal of Biological Chemistry.

[35]  B. Dewald,et al.  Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. , 1994, Advances in immunology.

[36]  R. Murali,et al.  The TNF receptor superfamily , 2003, Immunologic research.

[37]  M. Fresno,et al.  Biphasic control of nuclear factor‐χB activation by the T cell receptor complex: role of tumor necrosis factor α , 1995 .

[38]  Alan P. Wolffe,et al.  Transcription: In tune with the histones , 1994, Cell.

[39]  Allan R. Brasier,et al.  Tumor Necrosis Factor-α-inducible IκBα Proteolysis Mediated by Cytosolic m-Calpain , 1999, The Journal of Biological Chemistry.

[40]  M. Sinha,et al.  Identification of NF-kappaB-dependent gene networks in respiratory syncytial virus-infected cells. , 2002, Journal of virology.

[41]  James R. Johnson,et al.  Oscillations in NF-κB Signaling Control the Dynamics of Gene Expression , 2004, Science.

[42]  M. Caligiuri,et al.  Tumor Necrosis Factor-regulated Biphasic Activation of NF-κB Is Required for Cytokine-induced Loss of Skeletal Muscle Gene Products* , 2002, The Journal of Biological Chemistry.

[43]  W C Greene,et al.  NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. , 1993, Science.

[44]  A. Brasier,et al.  Interleukin-1-induced nuclear factor-kappaB-IkappaBalpha autoregulatory feedback loop in hepatocytes. A role for protein kinase calpha in post-transcriptional regulation of ikappabalpha resynthesis. , 1999, The Journal of biological chemistry.

[45]  Allan R. Brasier,et al.  Identification of Direct Genomic Targets Downstream of the Nuclear Factor-κB Transcription Factor Mediating Tumor Necrosis Factor Signaling* , 2005, Journal of Biological Chemistry.

[46]  Xin Chen,et al.  TRANSFAC: an integrated system for gene expression regulation , 2000, Nucleic Acids Res..

[47]  A. Hoffmann,et al.  The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. , 2002, Science.

[48]  Marek Kimmel,et al.  Mathematical model of NF- κB regulatory module , 2004 .

[49]  A. Fields,et al.  Interleukin-1-induced Nuclear Factor-κB-IκBα Autoregulatory Feedback Loop in Hepatocytes , 1999, The Journal of Biological Chemistry.

[50]  R. Garofalo,et al.  A promoter recruitment mechanism for tumor necrosis factor-alpha-induced interleukin-8 transcription in type II pulmonary epithelial cells. Dependence on nuclear abundance of Rel A, NF-kappaB1, and c-Rel transcription factors. , 1998, The Journal of biological chemistry.

[51]  A. Brasier,et al.  Nuclear factor-kappaB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation. , 1999, Blood.